What is the main business of Relax-Med?

The main business activity of Relax-Med focuses on manufacture of other medical instruments and supplies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 2, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Piasta 21, 44-200 Rybnik.

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

In 2024, the company generated total revenue of $6,868,693, representing an increase of 16.6% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $222,629, meaning the company increased its profit by 40.3%.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $4,499,400 in 2024, representing 68% of all operating expenses.

Relax-Medsp. z o.o.

Manufacture of other medical instruments and supplies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-05-02

Share capital

100 000,00 PLN

Registered address

ul. Piasta 21, 44-200 Rybnik, Poland

Electronic delivery address

AE:PL-53174-89078-JWIVT-26

Financials

Revenue history (in k)

Financial insight

Estonian CIT: Equity (Pasywa A) includes non-zero line items under Art. 28d of the Accounting Act — the filing indicates the lump-sum tax on company income.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 7.40mMedianUSD 848.96kAverageUSD 8.35m

Net profit

This companyUSD 122.31kMedianUSD 20.21kAverageUSD 574.87k

Operating costs

This companyUSD 7.25mMedianUSD 663.86kAverageUSD 7.41m

Assets

This companyUSD 2.86mMedianUSD 974.48kAverageUSD 6.92m

Industry

Bank accounts

Registered as a VAT taxpayer on 2018-05-02. Active

BNP Paribas Bank Polska
08 1750 0012 0000 0000 3980 2163
ING Bank Śląski
24 1050 1344 1000 0092 1991 6112
BNP Paribas Bank Polska
27 1750 0012 0000 0000 4111 4037

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

182 public aid cases recorded, with a total value of $1,018,691.

Grant date	Purpose	Gross amount	Granting body
Jul 10, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$4,419$4,419	Prezydent Miasta Rybnik
Jul 2, 2026	Aid in the form of wage subsidies for employing workers with disabilities	$2,319$2,319	Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych
Jun 2, 2026	Aid in the form of wage subsidies for employing workers with disabilities	$2,319$2,319	Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych

European Funds

6 projects co-financed from European Funds recorded, with total EU co-financing of $828,102.

Start	Project	EU co-financing	Programme
2026-06-01	„Zdrowy pracownik Relax-Med – Eliminowanie czynników ryzyka zdrowotnego w miejscu pracy”	$45,616$45,616	Fundusze Europejskie dla Śląskiego 2021-2027
2025-04-01	Poprawa efektywności energetycznej przedsiębiorstwa Relax-Med Sp.z.o.o., jako element transformacji energetycznej subregionu rybnickiego	$222.7K$222,736	Fundusze Europejskie dla Nowoczesnej Gospodarki
2025-01-01	Automatyzacja procesów produkcji i zarządzania poprzez wdrożenie automatyzacji ERP, analizę Big Data i wykorzystanie AI.	$161.8K$161,780	Fundusze Europejskie dla Śląskiego 2021-2027

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Adam Janusz Zostawa — President of the Management Board

Natalia Uścinowicz Zostawa — Attorney-in-fact (sole)

Ewa Zostawa — Management Board Member

Paweł Jan Zostawa — Management Board Member

Robert Piotr Zostawa — Management Board Member

Manner of representation

The President of the Management Board is authorized to submit declarations of will on behalf of the company independently, or two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Adam Janusz Zostawa (65)	2,000	$27,012.43	100%

Beneficial owners

Person	Rights
Adam Janusz Zostawa (65)	Shareholder of a limited liability company, 100000.0 PLN

Competitors

Name	Revenue	Website
Optopol Technologysp. z o.o.	$61,449,393.30	optopol.com.pl
Metrum CryoflexS.A.	$13,795,733.67	metrum.com.pl
SigvarisS.A.	$11,438,802.73	sigvaris.com
CM InternationalS.A.	$4,905,625.86	cos-medico.eu
Ziółkowski JuventasS.K.A.	$2,900,579.48	juventas.pl
WS Tech Lorenssp. j.	$2,722,397.69	wstech.eu
Si-Curasp. z o.o.	$1,631,852.12	si-cura.pl
AmbioP.S.A.	$1,357,457.41	ambio.com.pl
Stethomesp. z o.o.	$267,112.27	stethome.com
ChitomedP.S.A.	$206,587.41	chitomed.com

Change history

Date	Event
2025-10-29	PKD change (Removed: 32.50.Z, 47.19.Z, 47.91.Z, 77.29.Z, 86.90.A; Added: 32.50.B, 47.12.Z, 47.91, 77.22.Z, 86.95.Z)
2022-09-15	PKD change (Removed: 14.19.Z, 15.20.Z, 16.29.Z, 22.19.Z, 22.21.Z, 22.29.Z, 33.14.Z; Added: 46.46.Z, 47.19.Z, 47.72.Z, 47.91.Z, 77.29.Z, 85.59.B, 86.90.A)
2020-04-23	PKD change (Removed: 46.24.Z; Added: 88.10.Z)
2018-05-02	Entered in the register

FAQ

Last updated: 2026-07-13